HILARY AKPUDO: Open Payments
NPI 1437461530 · KINGWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 14 payments from 7 companies in 2025. Trend: 2023 $68 · 2024 $243 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $138 |
| E.R. Squibb & Sons, L.L.C. | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| Alkermes, Inc. | 1 | $19 |
| Luye Pharma (USA) Ltd. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: SPRAVATO, COBENFY, UZEDY, ARISTADA, ERZOFRI EXTENDED-RELEASE, INGREZZA, AUSTEDO XR, ABILIFY ASIMTUFII.
Industry payments across TX — which companies pay providers there.
